pMIR-mU6-Luc, Mouse U6 Luciferase Control Vector from Mirus Bio Corporation
Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference (RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can be synthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo. A convenient...pMIR-mU6, Mouse U6Template (Vector) from Mirus Bio Corporation
Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference(RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can besynthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo [1-4]. A conve...pMIR-hU6-Luc, Human U6 Luciferase Control Vector from Mirus Bio Corporation
Description:The potential applications for the use of small interfering RNA (siRNA) molecules to silence gene expression via the RNA interference (RNAi) pathway have generated tremendous interest in the cellular and molecular biology fields. siRNA for experimental use can be synthesized in vitro, either chemically or enzymatically, and then transfected into the target cells in vitro or in vivo. A convenient...Label IT Tracker CX-Rhodamine Intracellular Nucleic Acid Localization Kit from Mirus Bio Corporation
Description:...GPDH Assay Kit from Takara Mirus Bio
Description:The enzyme glycerol 3-phosphate dehydrogenase catalyzes a reversible reaction between dihydroxyacetone phosphate (DHAP) and glycerol 3-phosphate, with NAD as a coenzyme. GPDH activity increases significantly during differentiation of progenitor cells into adipocytes and, thus, the activity of this enzyme has been used as an index for monitoring fat synthesis. The Glycerol 3-Phosphate Dehydrogenas...Mirus Bio secures $900K grant to develop research tool
Mirus, a Madison-based life-science company engaged in gene therapy and the study of RNA interference, received the two-year grant from the <a href="http:/...Mirus Bio, Pfizer enter multimillion-dollar research agreement
Russell Smestad, president of Mirus Bio, said the lack of effective delivery methods has been an Achilles' heel th...Mirus Bio awarded patent on RNA delivery
The company has been working to address the lack of an effective method to deliver nucleic acids such as RNA for the study of gene function, and along wi...Mirus granted European patent for gene therapy
The pa...Mirus provides low-cost way to modify genes
, a privately-held biopharmaceutical firm, has developed a way to bypass the conventional hurdles associated with producing modified...